CECILIA ROBINSON: Open Payments
NPI 1487600607 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 43 payments from 12 companies in 2025. Trend: 2023 $576 · 2024 $732 · 2025 $872
Food & beverage: $834Education: $38
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $300 |
| AstraZeneca Pharmaceuticals LP | 10 | $194 |
| Novo Nordisk Inc | 3 | $85 |
| Lilly USA, LLC | 5 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Exact Sciences Corporation | 2 | $33 |
| PFIZER INC. | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
Products named: QULIPTA, AIRSUPRA, Ozempic, VRAYLAR, MOUNJARO, FARXIGA, JARDIANCE, BREZTRI.
Industry payments across AL — which companies pay providers there.
